Smead Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$60.7M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$51.7M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$33.2M |
| 4 |
Macerich
MAC
|
+$27.6M |
| 5 |
CLR
CONTINENTAL RESOURCES INC.
CLR
|
+$26.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Warner Bros
WBD
|
+$110M |
| 2 |
Walt Disney
DIS
|
+$11M |
| 3 |
Target
TGT
|
+$9.46M |
| 4 |
Accenture
ACN
|
+$9.4M |
| 5 |
Starbucks
SBUX
|
+$4.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 25.73% |
| 2 | Financials | 19.01% |
| 3 | Healthcare | 13.77% |
| 4 | Communication Services | 8.09% |
| 5 | Real Estate | 7.73% |
Similar funds
Smead Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Smead Capital Management held 37 positions worth $2.27B, up 31% from $1.73B the previous quarter. Its ten largest holdings account for 52% of the portfolio.
Smead Capital Management deployed $212M of net new capital in Q1 2021, opening 5 new positions and adding to 23 existing holdings. Its largest new stake was Discovery, Inc. Series C Common Stock: 1,218,844 shares worth $45M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Warner Bros, an estimated $110M trimmed.
- Smead Capital Management's largest Q1 2021 buy was Discovery, Inc. Series C Common Stock: 1,218,844 shares worth $45M.
- Smead Capital Management added most to Merck in Q1 2021, an estimated $60.7M increase.
- Smead Capital Management's biggest Q1 2021 reduction was Warner Bros, cutting an estimated $110M.
- Smead Capital Management fully exited Viatris in Q1 2021, selling an estimated $2.69M.
- Smead Capital Management's ten largest holdings make up 52% of its $2.27B portfolio in Q1 2021.
- Smead Capital Management opened 5 new positions and closed 2 in Q1 2021.
- Smead Capital Management's portfolio value rose 31% quarter-over-quarter to $2.27B.
Based on Smead Capital Management's 13F filing for Q1 2021, filed 4 May 2021.